Follow-up of patients with noninvasive and superficially invasive bladder cancer

Seminars in Urologic Oncology

Volumn 18, Issue 4, 2000, Pages 273-279

  Holmang, S ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bladder cancer; Cystoscopy; Follow up; Prognosis

Indexed keywords

BLADDER CANCER; BLADDER CARCINOMA; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CYSTOSCOPY; FOLLOW UP; HUMAN; PRIORITY JOURNAL; REVIEW;

CARCINOMA, TRANSITIONAL CELL; CYSTOSCOPY; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; TIME FACTORS; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROGRAPHY;

EID: 0033709976     PISSN: 10810943     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Histological typing of urinary bladder tumours
2. Prognostic parameters in superficial bladder cancer
3. The clinical epidemiology of superficial bladder cancer
4. Prospective registration of all patients in a geographical region with newly diagnosed bladder carcinomas during a two-year period
5. Transitional cell neoplasms of the urinary bladder: Can biologic potential be predicted from histologic grading?
6. Treated history of noninvasive grade 1 transitional cell carcinoma
7. Recurrence and progression in low grade papillary urothelial tumors
8. The World Health Organization/International Society of Urological pathology Consensus Classification of urothelial neoplasms of the urinary bladder
9. Urothelial atypia and survival rate of 500 unselected patients with primary transitional cell tumour of the urinary bladder
10. Differing interpretations by pathologists of the pT category and grade of transitional cell cancer of the bladder
11. A simplified grading method of transitional cell carcinoma of the urinary bladder: Reproducibility, clinical significance and comparison with other prognostic parameters
12. Stage progression in Ta papillary urothelial tumors: Relationship to grade, immuno-histochemical expression of tumor markers, mitotic frequency and DNA-ploidy
13. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years
14. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose Bacillus Calmette-Guerin instillations
15. The significance of lamina propria invasion on the prognosis of patients with bladder tumors
16. Long-term survival of patients with bladder tumours: The significance of risk factors
17. Tumor progression and survival of patients with high grade, noninvasive papillary (TAG3) bladder tumors: 15-year outcome
18. Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer
19. Muscularis mucosa differentiates two populations with different prognosis in stage T1 bladder cancer
20. Muscularis mucosa of urinary bladder: Importance for staging and treatment
21. Invasive carcinomas of the urinary bladder: Evaluation of tunica muscularis mucosal involvement
22. The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder
23. Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer
24. The importance of the depth of invasion in stage T1 bladder carcinoma: A prospective cohort study
25. The influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage T1 transitional cell bladder cancer
26. Use of ulex europaeus agglutinin I (UEA 1) to study vascular invasion in transitional cell carcinoma of bladder with submucosal invasion
27. Natural history of carcinoma in situ of the urinary bladder
28. Stage T1, grade 3 transitional cell carcinoma of the bladder: An unfavorable tumor?
29. Superficial bladder cancer: Progression and recurrence
30. Office flexible cystoscopy
31. Outpatient flexible cystoscopy and fulguration of recurrent superficial bladder tumors
32. Extirpation and fulguration of multiple superficial bladder tumour recurrences under intravesical lignocaine anaesthesia
33. A prospective trial of flexible cystodiathermy for recurrent transitional cell carcinoma of the bladder
34. The bladder tumor antigen (BTA) test compared to voided urine cytology in the detection of bladder neoplasms
35. Comparative sensitivity of urinary cyfra 21-1, urinary bladder cancer antigen, tissue polypeptide antigen and NMP 22 to detect bladder cancer
36. Superficial bladder tumors (stage pTa, grades 1 and 2): The importance of recurrence pattern following initial resection
37. Prognostic factors for recurrence and follow up policies in the treatment of superficial bladder cancer: Report from the British medical research council subgroup on superficial bladder cancer (urological cancer working party)
38. Follow-up of patients with 'superficial' transitional cell carcinoma of the bladder: The case for a change in policy
39. Can efficiency of follow-up for superficial bladder cancer be increased?
40. Proposal for changes in cystoscopic follow-up of patients with bladder cancer and adjuvant intravesical chemotherapy
41. Superficial bladder cancer: Timing of check cystoscopies in the first year
42. Proposal for changes in cystoscopic follow-up of patients with low-grade pTa bladder tumor
43. Phase II trials in Ta, T1 bladder cancer: The marker tumour concept
44. Late recurrence and progression after a long tumor-free period in primary Ta and T1 bladder cancer
45. Long-term follow-up of initial Ta grade 1 transitional cell carcinoma of the bladder
46. Late invasive recurrence despite long-term surveillance for superficial bladder cancer
47. Is routine excretory urography necessary at first diagnosis of bladder cancer?
48. Need for intravenous urography in patients with primary transitional carcinoma of the bladder?
49. Synchronous and metachronous transitional cell carcinoma of the urinary tract: Prevalence, incidence, and radiographic detection
50. Carcinoma of the renal pelvis and ureter following bladder carcinoma: Frequency, risk factors and clinicopathological findings
51. Long-term follow-up of a bladder carcinoma cohort: Routine follow-up urography is not necessary
52. Upper tract transitional cell carcinoma following treatment of superficial bladder cancer with BCG
53. Long-term follow-up of the upper urinary tract for transitional cell carcinoma: How much is enough?
54. Should the follow-up of patients with bladder cancer include routine excretory urography?